John Sigurd Mjøen Svendsen
Fondatore presso Pharmasum Therapeutics AS
Profilo
John Sigurd Mjøen Svendsen is the founder of Lytix Biopharma AS, which was founded in 2003.
He held the title of Board Member & Director-Discovery Research from 2012 to 2013.
Dr. Svendsen is also the founder of Pharmasum Therapeutics AS.
Currently, he is a Professor at the University of Tromso.
In the past, he worked as a Director at Prophylix AS and as a Professor at the Massachusetts Institute of Technology.
Dr. Svendsen obtained a doctorate degree from the University of Tromso.
Posizioni attive di John Sigurd Mjøen Svendsen
| Società | Posizione | Inizio |
|---|---|---|
| University of Tromso | Corporate Officer/Principal | 14/05/2009 |
Pharmasum Therapeutics AS
 Pharmasum Therapeutics AS BiotechnologyHealth Technology Pharmasum Therapeutics AS operates as a pharmaceutical company. The firm focuses on the discovery and development of novel human medicines for the treatment of brain diseases, especially neurological diseases. The company was founded by Anders Fugelli and John Sigurd Svendsen is headquartered in Kvaloysletta, Norway. | Fondatore | - |
Precedenti posizioni note di John Sigurd Mjøen Svendsen
| Società | Posizione | Fine |
|---|---|---|
Prophylix AS
 Prophylix AS Pharmaceuticals: MajorHealth Technology Prophylix AS operates as biotech company that offers orphan drug programs and follow-on therapy. The firm develops a prophylactic medicinal product to prevent newborns from Foetal/Neonatal Alloimmune Thrombocytopenia (FNAIT). The company was founded by Bjørn Ragnar Skogen, Jens Kjeldsen-Kragh, Anne Husebekk, and Mette Kjaer in 2008 and is headquartered in Tromso, Norway. | Direttore/Membro del Consiglio | - |
| Massachusetts Institute of Technology | Corporate Officer/Principal | - |
| LYTIX BIOPHARMA | Fondatore | - |
Formazione di John Sigurd Mjøen Svendsen
| University of Tromso | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| LYTIX BIOPHARMA | Health Technology |
| Aziende private | 2 |
|---|---|
Prophylix AS
Prophylix AS Pharmaceuticals: MajorHealth Technology Prophylix AS operates as biotech company that offers orphan drug programs and follow-on therapy. The firm develops a prophylactic medicinal product to prevent newborns from Foetal/Neonatal Alloimmune Thrombocytopenia (FNAIT). The company was founded by Bjørn Ragnar Skogen, Jens Kjeldsen-Kragh, Anne Husebekk, and Mette Kjaer in 2008 and is headquartered in Tromso, Norway. | Health Technology |
Pharmasum Therapeutics AS
Pharmasum Therapeutics AS BiotechnologyHealth Technology Pharmasum Therapeutics AS operates as a pharmaceutical company. The firm focuses on the discovery and development of novel human medicines for the treatment of brain diseases, especially neurological diseases. The company was founded by Anders Fugelli and John Sigurd Svendsen is headquartered in Kvaloysletta, Norway. | Health Technology |
- Borsa valori
- Insiders
- John Sigurd Mjøen Svendsen